Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

on expense of $6.9 million in the first nine months of 2008 compared with $4.5 million for the same period in 2007, and $3.6 million of depreciation and amortization expenses, compared with $2.9 million in the same period in 2007.

Recent Highlights and Accomplishments

Commercial Progress

-- More than 10,220 test results delivered in the third quarter of 2008,

compared with more than 5,950 test results delivered in the third

quarter of 2007, an increase of 72 percent year-over-year.

-- More than 75,000 Oncotype DX test results have been delivered to

patients.

-- Gained coverage for an additional 7.9 million lives for reimbursement

of Oncotype DX through contracts, policies and agreements, bringing the

total U.S. covered lives to approximately 89 percent of insured lives

including: Coventry Health Care (4.4 million lives), Blue Cross and

Blue Shield of Massachusetts (1.3 million lives), Medica Health Plans,

HMSA Blue Cross Blue Shield of Hawaii, and WPS Health Insurance in

Wisconsin.

-- Named a Vice President to oversee European markets.

-- Established distribution agreements in Australia and Taiwan.

-- Received test samples from 39 countries to date.

-- Oncotype DX included in the updated 2008 guidelines of the Dutch

Institute for Healthcare Improvement.

Product Pipeline

-- Enhanced clinical utility of Oncotype DX reports by including

quantitative HER2 scores; quantitative estrogen receptor and

progesterone receptor scores were added earlier this year.

-- Completed European study using Oncotype DX in node-negative and

node-positive, breast cancer patients treated with aromatase

inhibitors, which was accepted for oral presentation at the San Antonio

Breast Cancer Symposium in December 2008.

-- Continued to make progress toward a clinical validation
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... announced that its strategic partner VetStem Biopharma, Inc. ... study of AT-016, an adipose-derived allogeneic stem cell ... of osteoarthritis pain in dogs. The ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes are against the ... $697 million compared to $701 million in the second ... changes in foreign currency exchange rates decreased sales by ... By business unit, organic sales growth was 6% in ... , Reported diluted EPS was $0.98 compared to ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... (Q2 2015: +14% CER / 20% of sales) led the regional performance ... , as well as solid contributions from Korea, India ... Middle East / Africa (Q2 ... , Turkey and the United Kingdom ... 11%, excluding U.S. HPV sales, on demand across all customer classes. The top ...
Breaking Biology Technology:Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
... March 24 Industry sources estimate that U.S. ... energy costs alone. Hospital administrators planning ahead for ... such costs for the foreseeable future. Seeking systematic ... Energy and Environmental Design (LEED) criteria is one ...
... Preeminent Thought Leaders, will Examine Nanotechnology,s Role in ... TechConnect World, in association with the Nano ... Technology and Sustainable Industries Organization (CTSI), today announced ... at TechConnect World, May 3-7, at the George ...
... Month, Urging People Across the Country to Take Action ... AZN ) today announced the launch of ... Explorer -- a state-of-the-art, multisensory, motion simulator that helps ... inside the arteries. The Artery Explorer kicks off its ...
Cached Biology Technology:White Paper Shows How to LEED the Way With Green Design 2TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston 2TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston 3TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston 4AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 2AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 3AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 4
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/21/2015)... Connecticut , July 21, 2015  NXT-ID, ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet, announces that it has filed ... System and Method. This invention ... not only authorizes an account, but also the ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market ... Report: The Convergence of Commerce and Privacy" forecasts ... mobile biometric apps will be downloaded to smart ... The mobile biometrics market is projected to generate ... revenue during the seven-year forecast period.    ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... the University of Notre Dame,s Eck Institute for Global ... protein secretion, which could provide new insights into a ... Champions point out that bacteria use a variety of ... in order to interact with their environment. For bacterial ...
... Messe Fairground. When? 24 28 ... focussing on demonstrable science, policy and industry trends, benefiting ... 1,843 abstracts received from 74 countries, 337 keynote addresses ... of 1,460 organisations, 670 exhibitors registered and 30,000 visitors ...
... monkey is a prime conservation success story. These Brazilian ... a population on a private reserve has grown from just ... of the total remaining animals. As the population grows, ... phase of recovery as it begins to face the limitations ...
Cached Biology News:Notre Dame research could provide new insights into tuberculosis and other diseases 2Press invitation 2Press invitation 3Surprising demographic shifts in endangered monkey population challenge conservation expectations 2Surprising demographic shifts in endangered monkey population challenge conservation expectations 3
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Human Legumain Affinity Purified Polyclonal Ab...
Human Cystatin F MAb (Clone 292103)...
... an inhibitor of caspase-3/7 ... of inhibitor required to ... be determined empirically for ... inhibitor is sufficient to ...
Biology Products: